ÃÑ 67ÆäÀÌÁö

66ÆäÀÌÁö º»¹®½ÃÀÛ

°æ±âµµ ¿ä¾ç½Ã¼³ »çȸ¾à·á¼­ºñ½º µµÀÔ ¹× ½ÇÇà¹æ¾È
ambulatory setting. JAMA 2003.
30) Hajjar ER, et al. Adverse drug reaction risk factors in older outpatients. Am J Geriatr
Pharmacother 2003
31) ¹æÁؼ® ¿Ü. ³ëÀοä¾ç¿ø ÀÔ¼ÒÀÚÀÇ º¹¾à¼øÀÀµµ Çâ»óÀ» À§ÇÑ Æò°¡ÁöÇ¥ÀÇ °³¹ß ¹× ÀÓ»óÈ°¿ë. 2016
32) Kojiman T. The Need for Actions Against Polypharmacy in Older People With Frailty. 2018
33) Park HY,
et al. The Association between Polypharmacy and Dementia: A Nested Case-Control
Study Based on a 12-Year Longitudinal Cohort Database in South Korea. PLoS One. 2017
34) ÀϺ» ³»°¢ºÎ, 2019³â ÆÇ °í·É»çȸ ¹é¼­, 2019
35) Çѱ¹º¸°Ç»ê¾÷ÁøÈï¿ø, ÀϺ»ÀÇ °í·ÉÈ­ ÇöȲ ¹× °í·É»çȸ ´ëÃ¥, °í·É ģȭ »ê¾÷ Report, 2017
36) certain social security report of the social security system reform National Congress - Path of the
eye, 2013³â 8¿ù 6ÀÏ)
37) Canaday BR. OBRA¡¯90: A Practical Guide to Effecting Pharmaceutical Care. Washington DC:
American Pharmaceutical Association. 1994
38) Koda-kimble MA, Young LY, Kradjan WA, et al. Applied Therapeutics The Clinical Use of Drugs.
Lippincott Williams & Wilkins. 8th edition. 2005
39)Australian Government Department of Health. Medication management reviews. 2020
40)Dhillon AK, Hattingh HL, Stafford A, et al. General practitioner's perceptions on home medicines
reviews: a qualitative analysis. BMC FamPract 2015;16:16.
41) Dolovich L, Consiglio G, MacKeigan L, et al. Uptake of the MedsCheck annual medication review
service in Ontario community pharmacies between 2007 and 2013. Canadian Pharmacists Journal
2016;149(5):293-302
42) KOSIS, ½Ãµµº° ¿ä¾ç±â°ü ÇöȲ, 2019
43) KOSIS, ÀÇ·á±â°ü Á¾º° ȯÀÚ ¼ö, 2017~2018
44) ±Ç¼ø¸¸ µî, ³ëÀÎÀå±â¿ä¾çº¸Çè Á¦µµ ½ÃÇà 5³âÀÇ ¼º°úÆò°¡, 2013³â ±¹Á¦½ÉÆ÷Áö¾ö ÀÚ·áÁý
45) ±¹¹Î°Ç°­º¸Çè°ø´Ü, ³ëÀÎÀå±â¿ä¾çÅë°è¿¬º¸, °¢³âµµ
46) ÀÇ·á¹ý Á¦38Á¶, º°Ç¥ 5ÀÇ 2
47) °Ç°­º¸Çè½É»çÆò°¡¿ø, ¿ä¾çº´¿ø ÀûÁ¤¼º Æò°¡ 7Â÷, 2019
48) ±¹¹Î°Ç°­º¸Çè°ø´Ü, 2019 Àå±â¿ä¾ç ½ÇÅÂÁ¶»ç, 2020
49) ±¹¹Î°Ç°­º¸Çè, 2013³âµµ Àå±â¿ä¾ç ±â°ü ½Ã¼³±Þ¿© Æò°¡°á°ú ºÐ¼®º¸°í¼­
50) ±è¼º¿Á µî, ¿ä¾ç ½Ã¼³ ³ëÀÎ ´ë»ó ºÎÀûÁ¤ ¾à¹°»ç¿ëÇöȲ ¹× °ü¸®¹æ¾È °³¹ß ¿¬±¸º¸°í¼­, ±¹¹Î°Ç°­º¸Çè
°Ç°­º¸ÇèÁ¤Ã¥ ¿¬±¸¿ø ¿¬±¸º¸°í¼­ 2013-03
51) ½ÅÇöÁ¤. ³ëÀÎÆ÷°ýÆò°¡¸¦ ÅëÇÑ ³ëÀÎ ÀǷẹÁö ½Ã¼³ °ÅÁÖ ³ëÀÎȯÀÚÀÇ ¾à¹°»ç¿ë°ËÅä. ÀÌÈ­¿©ÀÚ´ëÇб³
¼®»çÇÐÀ§ ³í¹®. 2012
52) ÀÌ»óÀº. Medication Assessment and Impact of Pharmacist interventions in Elderly Patients. ¼­¿ï´ëÇÐ
±³ ¼®»çÇÐÀ§ ³í¹®. 2006
53) ·ùÀçÀº, ¼­¿¹¿ø, À̺´±¸, µî. ³ëÀÎÆ÷°ýÆò°¡ ½ÃÇà ÀüÈÄÀÇ ¾à¹°º¹¿ë ÇöȲ ¹× ó¹æ º¯È­. J Kor Soc
Health-Syst Pharm 2008; 25(2):121-132
54) ¼­¿¹¿ø. ³ëÀÎÀÇ·á¼¾ÅÍ¿¡¼­ ³ëÀÎÆ÷°ýÆò°¡¸¦ ÅëÇÑ ¾à¹°»ç¿ë °ËÅä. ¼­¿ï´ëÇб³ ¼®»çÇÐÀ§ ³í¹®. 2011
- 62 -

66ÆäÀÌÁö º»¹®³¡



ÇöÀç Æ÷Ä¿½ºÀÇ ¾Æ·¡³»¿ëµéÀº µ¿ÀÏÇÑ ÄÁÅÙÃ÷¸¦ °¡Áö°í ÆäÀÌÁö³Ñ±è È¿°ú¹× ½Ã°¢Àû È¿°ú¸¦ Á¦°øÇÏ´Â ÆäÀÌÁöÀ̹ǷΠ½ºÅ©¸°¸®´õ »ç¿ëÀÚ´Â ¿©±â±îÁö¸¸ ³¶µ¶ÇϽðí À§ÀÇ ÆäÀÌÁöÀ̵¿ ¸µÅ©¸¦ »ç¿ëÇÏ¿© ´ÙÀ½ÆäÀÌÁö·Î À̵¿ÇϽñ⠹ٶø´Ï´Ù.
»ó´Ü¸Þ´º ¹Ù·Î°¡±â ´ÜÃàÅ°¾È³» : ÀÌÀüÆäÀÌÁö´Â ÁÂÃø¹æÇâÅ°, ´ÙÀ½ÆäÀÌÁö´Â ¿ìÃø¹æÇâÅ°, ùÆäÀÌÁö´Â »ó´Ü¹æÇâÅ°, ¸¶Áö¸·ÆäÀÌÁö´Â ÇϴܹæÇâÅ°, ÁÂÃøÈ®´ëÃà¼Ò´Â insertÅ°, ¿ìÃøÈ®´ëÃà¼Ò´Â deleteÅ°